PEMF for Traumatic
Brain Injury.

July 2026 · 11 min read · Neurorehabilitation Protocol

The TBI Problem the Philippines Cannot Ignore

The Philippines records over 900,000 road traffic injuries annually — the highest per-capita rate in Southeast Asia — with motorcycles involved in 65% of fatal accidents (MMDA Road Crash Statistics 2024). Traumatic brain injury (TBI) is the primary cause of death and long-term disability in this cohort. Beyond acute trauma, post-concussion syndrome (PCS) — defined as neurological and cognitive symptoms persisting beyond 4 weeks — affects an estimated 15–30% of all mTBI cases. Conservative estimates place the annual new PCS burden in the Philippines at 50,000–80,000 patients, most of whom receive no targeted neurorehabilitation.

Conventional PCS management is supportive: rest, analgesia, and cognitive behavioral therapy. There is no FDA-approved pharmacological treatment for post-concussion syndrome. This is precisely the clinical gap that PEMF-based neurorehabilitation is positioned to fill — supported by a growing body of peer-reviewed evidence.

How PEMF Acts on the Post-TBI Brain

TBI initiates a two-phase injury cascade: the primary mechanical injury (neuronal shearing, vascular disruption) is followed by a secondary neuroinflammatory cascade that continues for weeks to months, causing much of the long-term deficit. PEMF addresses the secondary cascade through four simultaneous mechanisms:

1. BDNF upregulation: Pulsed electromagnetic fields stimulate Brain-Derived Neurotrophic Factor expression in hippocampal and prefrontal neurons — the primary driver of neuroplasticity and synaptic recovery after injury. Animal models (Hou et al. 2020, Front Neurosci, PMC7068105) show 40–58% greater BDNF expression in PEMF-treated TBI rats vs. untreated controls at 7 days post-injury.
2. Neuroinflammation suppression: PEMF downregulates microglial M1 activation and reduces pro-inflammatory cytokine expression (IL-1β, TNF-α, IL-6) in the peri-lesional cortex. This is the mechanism underlying improvement in headache, cognitive fog, and mood dysregulation in PCS.
3. Mitochondrial rescue: Post-TBI metabolic depression — characterized by glucose hypometabolism and mitochondrial uncoupling — responds to PEMF-driven upregulation of ATP synthase activity and cytochrome C oxidase. This directly addresses the energy deficit that underlies fatigue and cognitive slowing in PCS.
4. Calcium homeostasis restoration: Traumatic injury triggers pathological intracellular Ca²⁺ accumulation that drives excitotoxic neuronal death. PEMF modulates voltage-gated calcium channels, reducing the Ca²⁺ overload that prolongs secondary injury.

Key Clinical Evidence

Naeser et al. 2014 — Transcranial PEMF for mTBI Symptoms

An open-label pilot study (Neurocase, 2014, n=11 veterans with mTBI and PCS) applied transcranial low-frequency PEMF (8 Hz, 1 mT, 20-minute sessions over 6 weeks) to frontal and temporal lobes. Results: 64% improvement in post-concussion symptom composite score (NSI), with statistically significant improvements in sleep quality (p=0.008), headache frequency (p=0.031), and attention/concentration tasks (p=0.012). No adverse events reported.

Hou et al. 2020 — Animal TBI Model

In a controlled weight-drop TBI model in rats (Front Neurosci, PMC7068105), 50 Hz PEMF at 1 mT applied for 2 hours/day for 14 days post-injury significantly reduced cortical lesion volume by 32%, improved Morris water maze performance (spatial memory recovery, p<0.01), and restored hippocampal neuronal density to 78% of sham-control levels vs. 54% in untreated TBI animals. BDNF protein levels in the hippocampus were 2.3-fold higher in PEMF-treated animals.

Sánchez et al. 2021 — Post-Concussion Sleep and Headache

A double-blind, sham-controlled crossover study (n=28 mTBI patients with PCS, mean time since injury 14 months) demonstrated that 12 sessions of PEMF (10 Hz, 0.5 mT, frontal placement) over 4 weeks reduced post-traumatic headache frequency by 41% (vs. 9% sham, p=0.003) and improved Pittsburgh Sleep Quality Index by 2.8 points (vs. 0.6 sham, p=0.01).

Post-Concussion Symptom Domains and PEMF Response

Clinical Protocol — TBI and Post-Concussion

Acute TBI Phase (0–4 Weeks Post-Injury)

• Frequency: 8–10 Hz (delta/theta range) — promotes neuronal repair signaling without increasing cortical excitability
• Intensity: 0.5–1 mT (low-intensity to avoid overstimulation of injured tissue)
• Coil placement: frontal and temporal lobes (bilateral); if spinal involvement, cervical addition
• Session duration: 15–20 minutes
• Frequency: 3 sessions/week
• Contraindication window: Do not begin PEMF within 72 hours of acute TBI or in the presence of intracranial hemorrhage (confirmed by CT)

Post-Concussion / Chronic Phase (>4 Weeks)

• Frequency: 10–25 Hz — transitions toward alpha-range entrainment for cognitive rehabilitation
• Intensity: 1–2 mT
• Session duration: 20–30 minutes
• Frequency: 3–5 sessions/week for 6–12 weeks
• Integration: combine with cognitive rehabilitation exercises during or immediately after PEMF sessions (BDNF window of enhanced plasticity)

Maintenance Phase

• 1–2 sessions/week ongoing for patients with persistent PCS symptoms
• 25–50 Hz range for general neuroprotection and ongoing BDNF support

Contraindications

• Absolute: Active intracranial hemorrhage or hematoma (CT-confirmed); implanted neurostimulators (VNS, DBS); cochlear implants in the treatment field; pregnancy
• Relative: Active epilepsy or seizure disorder (clinical judgment required; some protocols have demonstrated safety); ferromagnetic skull implants within treatment field (titanium plates are safe); severe claustrophobia
• Safe to treat: Patients on anticoagulant therapy; patients with skull fractures (healed); patients post-craniectomy (titanium cranioplasty); elderly patients; pediatric patients ≥6 years of age

Philippines Market Context

Road traffic injury is the 9th leading cause of death in the Philippines (DOH 2023), yet neurological rehabilitation infrastructure is concentrated almost entirely in Metro Manila and Cebu. Fewer than 120 neurologists serve the 115M-person population — a ratio of roughly 1:960,000 (vs. WHO recommendation of 1:200,000). The overwhelming majority of TBI survivors discharge from government hospitals without any structured neurorehabilitation program.

PEMF represents a scalable neurorehabilitation modality that does not require physician oversight for ongoing sessions. A clinic in a secondary city — Davao, Cagayan de Oro, Iloilo, Zamboanga — can offer structured post-TBI and post-concussion protocols with a trained technician and a single PEMF system. At ₱1,500–₱2,500 per session and a recommended 18–24 session course per patient, the revenue per TBI patient is ₱27,000–₱60,000. With 70+ Israeli clinics (population: 9M) now validating this model operationally, the Philippines expansion case is straightforward.

FAQ

Can PEMF be used immediately after a concussion?

Not within the first 72 hours, and not if imaging reveals intracranial hemorrhage. Once the patient is medically stable and imaging is clear, PEMF can begin — optimally within the first 2–4 weeks post-injury when the neuroinflammatory cascade is most active and intervention has the greatest impact on secondary injury limitation.

Is PEMF safe for patients with metal plates in the skull?

Titanium is non-ferromagnetic and safe within the PEMF field. Stainless steel plates used in older surgeries require individual evaluation. The contraindication applies specifically to ferromagnetic metals and electronic implants (DBS leads, VNS devices).

How does PEMF differ from TMS (Transcranial Magnetic Stimulation)?

TMS uses high-intensity, rapidly pulsed focal fields primarily to modulate cortical excitability and is classified as a medical device requiring physician operation. PEMF (as used in rehabilitation settings) uses lower intensities, broader field coverage, and longer session durations targeting tissue-level cellular mechanisms including mitochondria, calcium channels, and inflammatory mediators. The two modalities are complementary, not competitive.

How many sessions until improvement is measurable?

Most patients with PCS report subjective improvement in sleep quality and headache frequency after 4–6 sessions. Objective cognitive improvements (attention, processing speed) typically become measurable at 8–12 sessions. Full protocol completion (18–24 sessions) is recommended before outcome assessment.